Access Bio Inc (950130) - Total Liabilities

Latest as of June 2025: ₩67.08 Billion KRW ≈ $45.46 Million USD

Based on the latest financial reports, Access Bio Inc (950130) has total liabilities worth ₩67.08 Billion KRW (≈ $45.46 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 950130 net asset momentum to track the company's year-over-year net asset growth rate.

Access Bio Inc - Total Liabilities Trend (2012–2024)

This chart illustrates how Access Bio Inc's total liabilities have evolved over time, based on quarterly financial data. See 950130 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Access Bio Inc Competitors by Total Liabilities

The table below lists competitors of Access Bio Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Everbrite Technology Co Ltd TWO:4523	Taiwan	NT$2.22 Billion
DDC Enterprise Limited NYSE MKT:DDC	USA	$843.97 Million
Astra Exploration Inc V:ASTR	Canada	CA$189.01K
Arovella Therapeutics Ltd AU:ALA	Australia	AU$1.33 Million
Sekuro Plastik Ambalaj Sanayi AS IS:SEKUR	Turkey	TL1.19 Billion
Elinoil Hellenic Petroleum Company S.A AT:ELIN	Greece	€373.37 Million
Shagrir Group Vehicle Services Ltd TA:SHGR	Israel	ILA343.78 Million
Northwest Copper Corp V:NWST	Canada	CA$1.66 Million

Liability Composition Analysis (2012–2024)

This chart breaks down Access Bio Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Access Bio Inc.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	15.67	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Access Bio Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Access Bio Inc (2012–2024)

The table below shows the annual total liabilities of Access Bio Inc from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩61.70 Million ≈ $41.81K	-99.94%
2023-12-31	₩104.00 Billion ≈ $70.48 Million	+49192.84%
2022-12-31	₩210.97 Million ≈ $142.97K	+60.93%
2021-12-31	₩131.10 Million ≈ $88.84K	+64.97%
2020-12-31	₩79.47 Million ≈ $53.86K	+103.73%
2019-12-31	₩39.01 Million ≈ $26.43K	-24.11%
2018-12-31	₩51.40 Million ≈ $34.83K	+11.67%
2017-12-31	₩46.03 Million ≈ $31.19K	+5.38%
2016-12-31	₩43.68 Million ≈ $29.60K	-98.97%
2015-12-31	₩4.24 Billion ≈ $2.87 Million	-59.04%
2014-12-31	₩10.35 Billion ≈ $7.01 Million	+15.08%
2013-12-31	₩8.99 Billion ≈ $6.09 Million	+21.79%
2012-12-31	₩7.38 Billion ≈ $5.00 Million	--

About Access Bio Inc

KQ:950130 Korea Diagnostics & Research

Market Cap

$51.25 Million

₩75.62 Billion KRW

Market Cap Rank

#21720 Global

#1276 in Korea

Share Price

₩2150.00

Change (1 day)

+4.88%

52-Week Range

₩2020.00 - ₩5390.00

All Time High

₩29950.00